Farallon Capital Management LLC Cara Therapeutics, Inc. Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

A detailed history of Farallon Capital Management LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 1,556,251 shares of CARA stock, worth $482,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,556,251

Previous 1,556,251 -0.0%

Holding current value

$482,437

Previous $404,000 19.31%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.65 $933,750 - $2.57 Million	1,556,251 New	1,556,251 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$1.67 - $3.33 $2.78 Million - $5.55 Million	1,666,591 New	1,666,591 $2.8 Million
Q2 2023 Aug 14, 2023	SELL	$2.83 - $4.94 $930,444 - $1.62 Million	-328,779 Reduced 16.48%	1,666,591 $4.72 Million
Q1 2023 May 15, 2023	SELL	$4.89 - $12.27 $385,478 - $967,244	-78,830 Reduced 3.8%	1,995,370 $9.8 Million
Q4 2022 Feb 14, 2023	SELL	$8.88 - $12.77 $3.78 Million - $5.44 Million	-425,800 Reduced 17.03%	2,074,200 $22.3 Million
Q1 2022 May 16, 2022	BUY	$9.94 - $12.65 $4.97 Million - $6.33 Million	500,000 Added 25.0%	2,500,000 $30.4 Million
Q2 2021 Aug 13, 2021	SELL	$12.38 - $29.19 $5.76 Million - $13.6 Million	-465,000 Reduced 18.86%	2,000,000 $28.5 Million
Q4 2020 Feb 16, 2021	BUY	$12.72 - $16.16 $2.73 Million - $3.47 Million	215,000 Added 9.56%	2,465,000 $37.3 Million
Q3 2020 Nov 16, 2020	SELL	$12.34 - $17.92 $617,000 - $896,000	-50,000 Reduced 2.17%	2,250,000 $28.6 Million
Q4 2019 Feb 13, 2020	BUY	$16.11 - $25.98 $2.42 Million - $3.9 Million	150,000 Added 6.98%	2,300,000 $37.1 Million
Q3 2019 Nov 14, 2019	BUY	$18.28 - $26.91 $21.9 Million - $32.3 Million	1,198,674 Added 126.0%	2,150,000 $39.3 Million
Q2 2019 Aug 14, 2019	BUY	$17.68 - $21.57 $16.8 Million - $20.5 Million	951,326 New	951,326 $20.5 Million

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account

Farallon Capital Management LLC Cara Therapeutics, Inc. Transaction History